Journal: The Lancet Haematology ISSN (E) 2352-3026 ISSN (L) 2352-3026
Publisher: (2674) Elsevier (Alias: Elsevier, Elsevier BV, Elsevier Ltd, Elsevier Inc., Elsevier Masson, Elsevier Australia, Elsevier Ltd., Elsevier BV * North-Holland, Elsevier Doyma, Elsevier Editora Ltda, Elsevier Espana, Elsevier France * Editions Scientifiques et Medicales, Elsevier GmbH, Elsevier GmbH - Urban und Fischer, Elsevier Health Sciences, Elsevier Ireland Ltd., Elsevier Japan KK, Elsevier Oncology, Elsevier Science Publishers Ltd., Elsevier S.A., Pergamon Press)

There are no additional documents for this Publisher/Journal.

Item Type:	Journal/Series
Publication Type:	Journal
Refereed:	Yes
OA Permissions:	Article Version Allowed Embargo S/R Policy Id Conditions License Copyright Owner Accepted Manuscript Yes 6 Months 1274 Publisher copyright and source must be acknowledged Must link to publisher version CC BY-NC-ND Published PDF No 1274 Published PDF No 3323 Published PDF Hybrid 3323 Published source must be acknowledged with citation CC BY Published PDF Hybrid 3323 Published source must be acknowledged with citation CC BY Published PDF Hybrid 3323 Published source must be acknowledged with citation CC BY-NC-ND 4.0
DOAJ:	No, journal is not listed in DOAJ
Additional Information:	Valid for articles published after May 1st, 2015: Author's post-print (accepted manuscript) on open access repository after an embargo period of between 12 months and 48 months see Journal Embargo Period List (pdf) (see link above "Publisher's Policy". This information is not valid for Open Access journals (see specific policy on website). Accepted manuscripts should be published under the CC-BY-NC-ND 4.0 license.
URL:	URL URL Type http://download.thelancet.com/flatcontentassets/authors/lancet-information-for-authors.pdf Guidelines for Authors http://www.thelancet.com/lancet/information-for-authors/disclosure-of-results Disclosure of results before publication http://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2813%2960720-5/fulltext The Lancet journals welcome a new open access policy http://www.thelancet.com/lancet-information-for-authors/after-publication What happens after publication? https://www.elsevier.com/__data/assets/pdf_file/0005/78476/external-embargo-list.pdf Journal Embargo Period List https://www.elsevier.com/__data/assets/pdf_file/0011/78473/UK-Embargo-Periods.pdf Journal Embargo List for UK Authors https://www.elsevier.com/about/open-science/open-access Open access https://www.elsevier.com/about/policies/open-access-licenses Open access licenses https://www.thelancet.com/lancet/about About The Lancet https://www.elsevier.com/open-access/journal-embargo-finder Journal Embargo Finder
Conflict:	No
Refereed Source:	Ulrichsweb
Sherpa Romeo Id:	31860
Divisions:	04 Faculty of Medicine > University Children's Hospital Zurich > Medical Clinic
Article Processing Charge(s):	Fee Currency Date 5000 USD 2015 5000 USD 2016 5000 USD 2017 5000 USD 2018
R&P Contract Details:	Contract Name/Title Period of validity Contract ID or number URL of web page
Date Deposited:	10 Feb 2017 10:57
Last Modified:	25 Feb 2023 01:15
URI:	https://www.jdb.uzh.ch/id/eprint/39014